Dr Gough Au

Work Phone	(02) 404 20253
Fax	(02) 404 20027
Email	Gough.Au@newcastle.edu.au
Office	2420, Hmri Building

Funding

Summary

Number of grants	9
Total funding	$595,774

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2011 (3 grants)

Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000
Funding Body: Maitland Cancer Appeal Committee

Project Team
Professor Phil Hansbro, Professor Paul Foster, Doctor Gough Au
Scheme		Role
Research Project		Investigator
Total Amount	Funding Start	Funding Finish
$50,000	2011	2011
GNo:G1100246

SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Phil Hansbro, Professor Paul Foster, Professor Joerg Mattes, Doctor Simon Keely, Doctor Jay Horvat, Doctor Nicole Hansbro, Doctor Ming Yang, Doctor Catherine Ptaschinski, Doctor Kelly Asquith, Doctor Gough Au, Conjoint Associate Professor Peter Wark, Laureate Professor John Aitken, Conjoint Professor Keith Jones, Professor Roger Smith, Professor Judith Black, Professor Rakesh Kumar, Professor Paul Hertzog
Scheme		Role
Equipment Grant		Investigator
Total Amount	Funding Start	Funding Finish
$45,000	2011	2011
GNo:G1100037

World Cancer Congress 2011, World Expo Center, Dalian, China, 22 - 25 May 2011$1,500
Funding Body: University of Newcastle - Faculty of Health

Project Team
Doctor Gough Au
Scheme	Role
Travel Grant	Chief Investigator
Total Amount	Funding Start	Funding Finish
$1,500	2011	2012
GNo:G1100576

2010 (1 grants)

Control of malignant glioma by naturally occurring oncolytic enteroviruses.$85,188
Funding Body: Cancer Australia

Project Team
Doctor Gough Au
Scheme	Role
Priority-driven Collaborative Cancer Research	Chief Investigator
Total Amount	Funding Start	Funding Finish
$85,188	2010	2011
GNo:G0190325

2009 (2 grants)

The use of Coxsackievirus A21 as a therapy for multiple myeloma and malignant glioma$30,000
Funding Body: Ramaciotti Foundations

Project Team
Doctor Gough Au
Scheme	Role
Establishment Grant	Chief Investigator
Total Amount	Funding Start	Funding Finish
$30,000	2009	2009
GNo:G0189325

5th International Meeting on Replicating Oncolytic Virus Therapeutics, Banff Canada, 18-21 March 2009$1,700
Funding Body: University of Newcastle - Faculty of Health

The University of Newcastle, Australia

Dr Gough Au

Funding

Summary

2011 (3 grants)

Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000
Funding Body: Maitland Cancer Appeal Committee

SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000
Funding Body: NHMRC (National Health & Medical Research Council)

World Cancer Congress 2011, World Expo Center, Dalian, China, 22 - 25 May 2011$1,500
Funding Body: University of Newcastle - Faculty of Health

2010 (1 grants)

Control of malignant glioma by naturally occurring oncolytic enteroviruses.$85,188
Funding Body: Cancer Australia

2009 (2 grants)

The use of Coxsackievirus A21 as a therapy for multiple myeloma and malignant glioma$30,000
Funding Body: Ramaciotti Foundations

5th International Meeting on Replicating Oncolytic Virus Therapeutics, Banff Canada, 18-21 March 2009$1,700
Funding Body: University of Newcastle - Faculty of Health

2008 (1 grants)

New Staff Grant$5,379
Funding Body: University of Newcastle

2007 (2 grants)

Coxsackievirus A21 virotherapy of multiple myeloma and malignant glioma$369,000
Funding Body: NHMRC (National Health & Medical Research Council)

The use of Coxsackie B group viruses as potential treatments for human gastric and colorectal cancers$8,007
Funding Body: University of Newcastle

The University of Newcastle, Australia

Dr Gough Au

Funding

Summary

2011 (3 grants)

Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000 Funding Body: Maitland Cancer Appeal Committee

SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000 Funding Body: NHMRC (National Health & Medical Research Council)

World Cancer Congress 2011, World Expo Center, Dalian, China, 22 - 25 May 2011$1,500 Funding Body: University of Newcastle - Faculty of Health

2010 (1 grants)

Control of malignant glioma by naturally occurring oncolytic enteroviruses.$85,188 Funding Body: Cancer Australia

2009 (2 grants)

The use of Coxsackievirus A21 as a therapy for multiple myeloma and malignant glioma$30,000 Funding Body: Ramaciotti Foundations

5th International Meeting on Replicating Oncolytic Virus Therapeutics, Banff Canada, 18-21 March 2009$1,700 Funding Body: University of Newcastle - Faculty of Health

2008 (1 grants)

New Staff Grant$5,379 Funding Body: University of Newcastle

2007 (2 grants)

Coxsackievirus A21 virotherapy of multiple myeloma and malignant glioma$369,000 Funding Body: NHMRC (National Health & Medical Research Council)

The use of Coxsackie B group viruses as potential treatments for human gastric and colorectal cancers$8,007 Funding Body: University of Newcastle

Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000
Funding Body: Maitland Cancer Appeal Committee

SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000
Funding Body: NHMRC (National Health & Medical Research Council)

World Cancer Congress 2011, World Expo Center, Dalian, China, 22 - 25 May 2011$1,500
Funding Body: University of Newcastle - Faculty of Health

Control of malignant glioma by naturally occurring oncolytic enteroviruses.$85,188
Funding Body: Cancer Australia

The use of Coxsackievirus A21 as a therapy for multiple myeloma and malignant glioma$30,000
Funding Body: Ramaciotti Foundations

5th International Meeting on Replicating Oncolytic Virus Therapeutics, Banff Canada, 18-21 March 2009$1,700
Funding Body: University of Newcastle - Faculty of Health

New Staff Grant$5,379
Funding Body: University of Newcastle

Coxsackievirus A21 virotherapy of multiple myeloma and malignant glioma$369,000
Funding Body: NHMRC (National Health & Medical Research Council)

The use of Coxsackie B group viruses as potential treatments for human gastric and colorectal cancers$8,007
Funding Body: University of Newcastle